Last reviewed · How we verify

Methylprednisolone/prednisolone — Competitive Intelligence Brief

Methylprednisolone/prednisolone (Methylprednisolone/prednisolone) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Corticosteroid (glucocorticoid). Area: Immunology, Rheumatology, Endocrinology.

marketed Corticosteroid (glucocorticoid) Glucocorticoid receptor (GR) Immunology, Rheumatology, Endocrinology Small molecule Live · refreshed every 30 min

Target snapshot

Methylprednisolone/prednisolone (Methylprednisolone/prednisolone) — Chong Kun Dang Pharmaceutical. Methylprednisolone and prednisolone are corticosteroids that suppress the immune system and reduce inflammation by binding to glucocorticoid receptors and inhibiting pro-inflammatory cytokine production.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Methylprednisolone/prednisolone TARGET Methylprednisolone/prednisolone Chong Kun Dang Pharmaceutical marketed Corticosteroid (glucocorticoid) Glucocorticoid receptor (GR)
Dexamethasone / Prednisolone Dexamethasone / Prednisolone Johann Wolfgang Goethe University Hospital marketed Corticosteroid (glucocorticoid) Glucocorticoid receptor (GR)
Celestone + Celestone Celestone + Celestone McMaster University marketed Corticosteroid (glucocorticoid) Glucocorticoid receptor (GR)
corticosteroids (Aprednislon) corticosteroids (Aprednislon) Ingrid Pabinger, MD marketed Corticosteroid (glucocorticoid) Glucocorticoid receptor (GR)
Prednisolone, prednisone, or methylprednisolone Prednisolone, prednisone, or methylprednisolone Children's Hospital of Philadelphia marketed Corticosteroid (glucocorticoid) Glucocorticoid receptor (GR)
Oral prednisolone Taper Oral prednisolone Taper Berinstein, Jeffrey marketed Corticosteroid (glucocorticoid) Glucocorticoid receptor (GR)
Solu-medrol or placebo administration Solu-medrol or placebo administration Erasme University Hospital marketed Corticosteroid (glucocorticoid) Glucocorticoid receptor (GR)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Corticosteroid (glucocorticoid) class)

  1. Assistance Publique - Hôpitaux de Paris · 3 drugs in this class
  2. Astellas Pharma Inc · 2 drugs in this class
  3. Sanofi · 2 drugs in this class
  4. Xinqiao Hospital of Chongqing · 2 drugs in this class
  5. Berinstein, Jeffrey · 2 drugs in this class
  6. Ain Shams University · 2 drugs in this class
  7. Children's Hospital of Philadelphia · 1 drug in this class
  8. Celgene · 1 drug in this class
  9. Hamilton Health Sciences Corporation · 1 drug in this class
  10. Erasme University Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Methylprednisolone/prednisolone — Competitive Intelligence Brief. https://druglandscape.com/ci/methylprednisolone-prednisolone. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: